Graphite & Graphene Week-in-Review: sector heading in the right direction; Focus/Grafoid make headlines (again)
Graphite & Graphene Week-in-Review (August 30 – September 6, 2013): The InvestorIntel Graphite & Graphene members stock performance is heading in the right direction — up slightly last week, gaining +0.28% overall. It was a shortened work week in the US and Canada with the Labor/Labour Day holiday, so there wasn’t a whole lot of news. But quantity has no reflection on quality as evidenced by the very promising and exciting graphene news that will be of interest to anyone who has been directly or indirectly touched by cancer… like my mother, who almost died from stage IV lung cancer.
Focus Graphite Inc. (TSXV: FMS | OTCQX: FCSMF) may have been a little up and a little down on the American and Canadian exchanges respectively, but the real news was what Focus’ partner Grafoid Inc. announced on September 5th. Grafoid (if you don’t know about Grafoid and you’re into graphene, you really have to check Grafoid out) announced the formation of Calevia Inc. — a joint-venture partnership with ProScanRx Pharma Inc. to develop an entirely new graphene-based nanotechnology platform for the precise targeting and thermal eradication of solid cancer tumors. Yes, graphene and possible cancer treatment! Focus and Grafoid President and CEO Gary Economo commented:
“Calevia’s unique targeted photothermal therapy aim to overcome the side effects and strong limitations of common cancer therapies, such as surgery, radiation and chemotherapy. Calevia sets a clear example to the world how graphene technologies serve humanity.”
Gary further explained that the Calevia partnership combines ProScan’s established cellular antibody targeting technologies with Grafoid’s patent-pending MesoGraf Xide graphene to eradicate cancer cells in a non-invasive manner. I’m a big fan of graphene trailblazer Dr. Gordon Chiu (he’s the co-founder of Grafoid and Focus’ head scientist) and he serves as co-manager and advisor to Calevia. Tracy mentioned to me that the great Dr. Luc Duchesne would be writing about this, so be on the lookout for that article.
Highlights of the past week:
Lomiko Metals Inc. (TSXV: LMR | OTCQX: LMRMF) was up +16.94% for the week on the American exchange, without any news. I said it last week, but I’ll say again (and actually do it this time)… I look forward to an update with Paul Gill today or tomorrow. I am anxious to find out what Lomiko and collaborating partner Graphene Laboratories are up to.
Shares in Flinders Resources Ltd. (TSXV: FDR) were up +9.26% last week on the September 3rd announcement of the positive preliminary economic assessment (PEA) of the company’s 100% owned and fully permitted Woxna Graphite Project, centrally located in the Kingdom of Sweden. I have always been fond of Flinders and I’m not alone; so have many investors. You may recall that Flinders had a “July to remember” when the company’s stock price jumped a whopping +79.22% for the month.
Get our daily investorintel update
InvestorIntel is a trusted source of reliable information at the forefront of emerging markets that brings investment opportunities to discerning investors.